Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 3, 2013, Pages 574-579

  Billè, Andrea ^a   Okiror, Lawrence ^a   Skanjeti, Andrea ^b   Errico, Luca ^c   Arena, Vincenzo ^b   Penna, Daniele ^b   Ardissone, Francesco ^c   Pelosi, Ettore ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IRMET   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Accuracy; Adenocarcinoma; Lymph node staging; PET CT; Squamous cell carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THORACOTOMY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 84873637861     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs366     Document Type: Article

References (19)

1. Rusch VW, Crowley J, Giroux DJ, Goldstraw P, Im JG, Tsuboi M et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:603-12.
2. De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M et al. ESTS guidelines for preoperative lymph node staging for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2007;32. 32:1-8.
3. Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D et al. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 2009;36:731-6.
4. Bille A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 2009; 36:440-5.
5. Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Merrbeeck JP, Kelles A. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Thorax 2007;62:696-701.
6. Melek H, Gunluoglu MZ, Demir A, Akin H, Olcmen A, Dincer SI. Role of positron emission tomography in mediastinal lymphatic staging of nonsmall cell lung cancer. Eur J Cardiothorac Surg 2008;33:294-9.
7. Metin M, Citak N, Sayar A, Pekcolaklar A, Melek H, Kök A et al. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures? J Thorac Oncol 2011;6:1713-9.
8. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P et al. Members of IASLC Staging. The IASLC Lung Cancer Staging Project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:568-77.
9. Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma? Thorac Cardiovasc Surg 2012;60:166-21.
10. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003;139: 879-92.
11. Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L et al. Mediastinal lymph nodes staging by (18)F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study. Radiother Oncol 2012;102: 246-50.
12. Lu P, Yu L, Li Y, Sun Y. A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer. Nucl Med Commun 2010;31:646-51.
13. Li M, Sun Y, Liu Y, Han A, Zhao S, Ma L et al. Relationship between primary lesion FDG uptake and clinical stage at PET-CT for nonsmall cell lung cancer patients: an observation. Lung Cancer 2010;68: 394-7.
14. 18F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan. J Thorac Oncol 2011;6:1697-703.
15. de Geus-Oei LF, van Krieken JH, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF et al. Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79-87.
16. Suzawa N, Ito M, Qiao S, Uchida K, Takao M, Yamada T et al. Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/ CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size. Lung Cancer 2011;72:191-8.
17. Ketchedjian A, Daly BD, Fernando HC, Florin L, Hunter CJ, Morelli DM et al. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2006;132:544-8. Epub 2006 Jul 31.
18. Watanabe S, Suzuki K, Asamura H. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis. Ann Thorac Surg 2008;85:1026-31.
19. Kim AW. Lymph node drainage patterns and micrometastasis in lung cancer. Semin Thorac Cardiovasc Surg 2009;21:298-308.